Search

Author/Creator Polverelli, N.

1. P1010: RUXOLITINIB IN MYELODEPLETIVE MYELOFIBROSIS: RESPONSE, TOXICITY, AND OUTCOME. (23rd June 2022)

Authors:
Palandri, F.; Bartoletti, D.; Breccia, M.; Auteri, G.; Elli, E. M.; Trawinska, M. M.; Polverelli, N.; Tiribelli, M.; Benevolo, G.; Iurlo, A.; Tieghi, A.; Heidel, F. H.; Caocci, G.; Beggiato, E.; Binotto, G.; Cavazzini, F.; Miglino, M.; Bosi, C.; Crugnola, M.; Bocchia, M.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
900
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P1011: PREDICTORS OF COVID-19 DISEASE AND SURVIVAL TO COVID-19 IN MPN PATIENTS TREATED WITH RUXOLITINIB. (23rd June 2022)

Authors:
Palandri, F.; Bartoletti, D.; Elli, E. M.; Auteri, G.; Bonifacio, M.; Benevolo, G.; Heidel, F.; Trawinska, M. M.; Rossi, E.; Bosi, C.; Tieghi, A.; Tiribelli, M.; Iurlo, A.; Polverelli, N.; Caocci, G.; Binotto, G.; Cavazzini, F.; Beggiato, E.; Cilloni, D.; Tatarelli, C.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
901
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY. (23rd June 2022)

Authors:
Farina, M.; Chiarini, M.; Almici, C.; Beghin, A.; Accorsi Buttini, E.; Galvagni, A.; Ferrari, E.; Bianchetti, A.; Zuccalà, F.; Piva, S.; Volonghi, I.; Poli, L.; Moratto, D.; Leoni, A.; Re, F.; Bosio, K.; Bernardi, S.; Polverelli, N.; Turra, A.; Morello, E.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1332
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA. (23rd June 2022)

Authors:
Accorsi Buttini, E.; Farina, M.; Turra, A.; Morello, E.; Polverelli, N.; Colnaghi, F.; Almici, C.; Ferrari, E.; Bianchetti, A.; Leoni, A.; Re, F.; Bosio, K.; Bernardi, S.; Malagola, M.; Re, A.; Russo, D.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
2079
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment‐related risk factors. (16th July 2014)

Authors:
Ruggeri, M.; Tosetto, A.; Palandri, F.; Polverelli, N.; Mazzucconi, M. G.; Santoro, C.; Gaidano, G.; Lunghi, M.; Zaja, F.; De Stefano, V.; Sartori, R.; Fazi, P.; Rodeghiero, F.; the Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) Anemia and Thrombocytopenias Working Party. GIMEMA Study...
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 12:Number 8(2014:Aug.)
Page Start:
1266
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search